PharmaCyte Biotech, Inc. (PMCB)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. NV
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-07 | Silverman Joshua | director | P | 40,000 | 0.83 | $33,200 |
| 2026-01-07 | SCHECHTER JONATHAN | director | P | 20,000 | 0.84 | $16,800 |
| 2026-01-06 | Silverman Joshua | director | P | 30,000 | 0.79 | $23,700 |
| 2026-01-06 | SCHECHTER JONATHAN | director | P | 20,000 | 0.79 | $15,800 |
| 2026-01-05 | Silverman Joshua | director | P | 30,000 | 0.78 | $23,400 |
| 2026-01-05 | SCHECHTER JONATHAN | director | P | 20,000 | 0.78 | $15,600 |
| 2025-12-12 | WEINSTEIN ROBERT | director | A | 75,000 | 0 | $0 |
| 2025-12-12 | WEINSTEIN ROBERT | director | F | 33,750 | 1.02 | $34,425 |
| 2025-12-12 | WALKER WAYNE REMELL | director | F | 16,875 | 1.02 | $17,213 |
| 2025-12-12 | WALKER WAYNE REMELL | director | A | 37,500 | 0 | $0 |
| 2025-12-12 | Silverman Joshua | director | A | 575,000 | 0 | $0 |
| 2025-12-12 | Silverman Joshua | director | F | 258,750 | 1.02 | $263,925 |
| 2025-12-12 | SCHECHTER JONATHAN | director | F | 67,500 | 1.02 | $68,850 |
| 2025-12-12 | SCHECHTER JONATHAN | director | A | 150,000 | 0 | $0 |
| 2025-12-12 | Abecassis Michael M | director | A | 37,500 | 0 | $0 |
| 2025-12-12 | Abecassis Michael M | director | F | 16,875 | 1.02 | $17,213 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.